Chinese materia medica preparation for curing bronchitis

Abstract

The invention discloses a Chinese materia medica preparation for curing bronchitis, which comprises the following raw materials in parts by weight: 10 to 12 parts of schisandra chinensis, 6 to 10 parts of codonopsis pilosula, 4 to 7 parts of cimicifugae foetidae, 8 to 9 parts of lumbricus, 7.5 to 9.5 parts of burdock, 8 to 10 parts of cordate houttuynia, 8 to 11 parts of dried tangerine or orange peel, 3 to 5 parts of roasted perilla seed, 4.5 to 6.5 parts of scutellaria baicalensis, 8 to 10 parts of angelica sinensis, 7 to 9 parts of bletilla striata, 4.5 to 6.5 parts of thunberg fritillary bulb, 9 to 12 parts of asparagus cochinchinensis, 5 to 7 parts of folium eriobotryae, 4 to 6 parts of radix stemonae, 1 to 3 parts of finelydivided phtheirospermum, 6 to 8 parts of linear leaf speedwell, 10 to 11 parts of lilium brownie, 7 to 9 parts of honey-fried licorice root, 5 to 8 parts of rock candy, 1.5 to 2.5 parts of heterophyllous wing seedtree root, 7 to 10 parts of hyacinth orinntal leaf, 2 to 4 parts of pteris cretica, and 1.5 to 2 parts of earthstar; through rational combination of pure Chinese herbal medicines, the Chinese materia medica preparation for curing the bronchitis has obvious curative effect on bronchitis, is capable of treating both manifestation and root cause of disease, is high in cure rate, has the efficacy of nourishing cough and moistening lung, clearing away heat and toxic materials, relieving cough and reducing sputum, smoothing lung and relieving asthma, eliminating phlegm and expelling pus, relieving lung and ventilating, activating blood circulation to dissipate stasis, diminishing inflammation and sterilizing, and the like, has the advantages of good safety, no toxic and side effect, simple manufacturing and low cost, and is required by patients.

Description

technical field [0001] The invention relates to a traditional Chinese medicine preparation for treating bronchitis, which belongs to the field of traditional Chinese medicines. Background technique [0002] Bronchitis is a common and frequently-occurring disease of the respiratory system, which refers to chronic non-specific inflammation of the trachea, bronchial mucosa and surrounding tissues. It is a chronic inflammatory disease of the airways involving a variety of cells and cellular components. The disease generally progresses slowly, and is prone to repeated attacks, often secondary to obstructive emphysema, even pulmonary hypertension, cor pulmonale, which seriously endangers people's health. The main clinical manifestations are paroxysmal dyspnea accompanied by wheezing, cough, dry cough and sputum production, often exacerbated at night and early morning. At present, clinical treatment is mainly controlled by hormones and other methods, which is not only expensive...

AI Technical Summary

Problems solved by technology

At present, clinical treatment is mainly controlled by hormones and other methods, which is not on